| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet," the "Company," "we," "us" or "our"), a leader in AI-powered Real-World Data (RWD), announced a strategic partnership with Medcase, a worldwide network of healthcare professionals focused on medical data annotation. This collaboration establishes a new market entry point for OneMedNet and opens a high-growth revenue channel in the healthcare AI ecosystem.
Strategic Expansion into Healthcare Data Annotation
The global healthcare data annotation market, valued at $1.5 billion in 2025 and projected to be $2.8 billion by 2030, has entered a pivotal growth phase1. Scale AI's $14.8B investment from Meta has disrupted the industry, triggering an exodus of major clients concerned about competitive intelligence. This shift has created an immediate opportunity for specialized providers focused solely on healthcare—where regulatory compliance, domain expertise, and trust are paramount. With Medcase's 15,000+ healthcare professionals delivering world-class annotation services, OneMedNet gains a strategic foothold in this fast-growing market, expanding beyond RWD into a complementary and recurring revenue stream.
Posted In: ONMD
